MaaT Pharma provides a broad overview of its recent activities and expected milestones. We can expect a number of updates from MaaT's pipeline in the coming months, the most notable of which is the primary endpoint readout (28 day GI-ORR) from the Ph3 ARES trial of enema MaaT013 in aGvHD, which is expected mid 4Q24. We reiterate our € 15 TP and Buy rating.
LYON, France--(BUSINESS WIRE)-- Regulatory News: (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET)1 visant à améliorer la survie des patients atteints de cancers, fait le point sur ses activités et rappelle les principales étapes attendues pour l’année 2024. Hervé Affagard, directeur général et co-fondateur de MaaT Pharma, a déclaré : « nous avançons avec confiance vers les résultats de la Phase 3 pour MaaT013, tout en continuant à atteindre des jalons clés et à créer de la valeur...
LYON, France--(BUSINESS WIRE)-- Regulatory News: (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer, today provided a business update and highlights its key milestones for 2024. Hervé Affagard, CEO and co-founder of MaaT Pharma said: “We're confidently advancing towards Phase 3 results for MaaT013, meeting milestones and delivering value for shareholders. Recent data at the EBMT annual congress underscores MaaT013's potential in aGvHD whe...
LYON, France--(BUSINESS WIRE)-- Regulatory News: (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem Therapies™ (MET)1 visant à améliorer la survie des patients atteints de cancers, publie le nombre d'actions composant son capital et le nombre total de droits de vote (articles L. 233-8 II du code de commerce et 223-16 du règlement général de l'AMF) au 30 avril 2024. Place de cotation : Euronext Paris Code ISIN : FR0012634822 Site web : Date Nombre total d’actions composant le capital...
1Q24 sales decreased 5.3% to € 993m, or 3.2% below CSS expectations driven by soft results in N-A. Although the 1Q24 adj. EBIT of € 62.1m came in below expectations (kbcse: € 71.6m, css: € 69.7m), we want to highlight that the adj. EBIT was impacted by € 7.7m in M&A costs related to the Staci acquisition. Excluding this effect, profitability was in line with expectations driven by solid cost savings in E-logistics. Additionally, bpost mentioned that it does not expect any restructuring costs in ...
Founded in 1959, Leifheit AG is one of the leading European brand suppliers of household items. The group divides its operating business into the household, wellbeing and private label segments. In view of its growing turnover (CAGR of +2.8% for 2023 to 2026e) and EBIT margins (+290bp to 5.2% in 2026e vs 2023), as well as its solid financial profile (equity ratio of about 50%, average net cash position of c. € 40m for 2024e to 2026e, average positive FCF of c. € 11m for 2024e to 2026e...
Founded in 1959, Leifheit AG is one of the leading European brand suppliers of household items. The group divides its operating business into the household, wellbeing and private label segments. In view of its growing turnover (CAGR of +2.8% for 2023 to 2026e) and EBIT margins (+290bp to 5.2% in 2026e vs 2023), as well as its solid financial profile (equity ratio of about 50%, average net cash position of c. € 40m for 2024e to 2026e, average positive FCF of c. € 11m for 2024e to 2026e...
>2024 guidance confirmed based on broadly robust operating momentum - Shurgard’s Q1 2024 earnings report (i.e. revenues of € 93.4m; growth at current scope and constant forex rate at +7.1%) reflects the continuation of a broadly solid operating performance:Shurgard continues to benefit overall from good rental pressure with a same-store occupancy rate at 89.2% (i.e. a 60bp decline q-o-q) close to its 90% target and average in-place rent growth of 4.8% y-o-y. By c...
Aperam: In-line 1Q24 EBITDA, FCF marked by WC build, 2Q24 guidance below consensus. Ayvens: Taking the brakes off. BAM: Not the best start to the year. bpost: 1Q24 in line with consensus but beat vs INGF, no outlook yet. Brunel International: good set of 1Q24 results – 5% beat on EBIT, comforting trends. B&S Group: Preview - should be a non-event. DEME Group: Preview - should be a non-event. D'Ieteren: Febiac April registrations flat YoY, VW brands up 8.4%. GBL: NAV per share in ...
>Guidance 2024 confirmée sur la base d’une dynamique opérationnelle globalement stable - La publication de Shurgard sur le T1 24 (i.e. revenus à 93.4 M€ ; croissance à périmètre courant et taux de change constants à +7.1%) traduit le maintien d’une performance opérationnelle globalement stable :Shurgard continue de bénéficier globalement d’une bonne tension locative avec un taux d’occupation « same stores » à 89.2% (soit une baisse de 60 pb yoy) proche de sa cibl...
Shurgard 1Q24 results came slightly below our estimates as increased RE-taxes hit 1Q harder than expected. Also 4.0% lfl operating revenue growth came below our 4.7% expectation. The EPRA Earnings amounted to EUR 34.2m, +12.6% yoy vs. our expectation of 35.3m. Guidance FY24 excludes the Lok'nStore bid and indicates a 7.5% revenue growth in line with our previous estimates. The balance sheet offers ample headroom with LTV at 14.6%. The results still show a resilient operational performance, impa...
>Top-line pressures and one-off costs - Bpost experienced pressure on both its Q1 24 revenues as well as its operating earnings. Group operating income (i.c. revenue) for the quarter came in at € 993m and adjusted EBIT at € 62m, respectively -3% and -11% vs. ccs, and -6% and -3% vs. our estimates. Bpost’s results continue to be driven by (a slowing) Belgium and E-Logistics Eurasia, while E-Logistics NA performed poorly once again due to challenging market conditions. ...
• The Q1-24 REBIT was somewhat below expectations, mainly on higher corporate costs. No concrete FY24 guidance as not all negotiations on press distribution are finalized yet and impact is still unclear.• The planned acquisition of Staci can strategically be justified, but in our view it looks stretched financially, both on multiple paid and on resulting leverage. • Although multiples appear undemanding, we stick to Hold. There are still many uncertainties.
In this May edition of our Dynamic Top Pick List we replace Arcadis by Fugro. Arcadis continues to deliver consistently on its promises and is working hard to realise its 2026 margin targets via cross selling, leveraging its global engineering platform and numerous self-help measures. In spite of this we remove Arcadis from our Dynamic Top Pick List as the recent & strong share price performance leaves little room for further short term triggers As a service provider to the energy industry, Fu...
Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: results of Simplified Squeeze-Out Acceptance Period of TPG on Intervest Dear Madam, Sir, Please find hereunder the links to Intervest Offices & Warehouses’ latest press release regarding the results of Simplified Squeeze-Out Acceptance Period of TPG on Intervest. Geachte mevrouw, meneer, Gelieve hierbij de links te vinden naar het recente persbericht van Intervest Offices & Warehouses betreffende de resultaten aan van de Aanvaardingsperiode van het vereenvoudigd uitkoopbod van TPG op Intervest. ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.